- Bridges outduels Wembanyama, Celtics lose again
- Hungry Sabalenka ready for more Slam success
- Mass jailbreak in Mozambique amid post-election unrest
- Azerbaijani jet crashes in Kazakhstan, killing 38
- Bridges outduels Wembanyama as Knicks beat Spurs
- 2004 Indian Ocean tsunami: what to know 20 years on
- Asia to mourn tsunami dead with ceremonies 20 years on
- Syrians protest after video of attack on Alawite shrine
- Russian state owner says cargo ship blast was 'terrorist attack'
- 38 dead as Azerbaijani jet crashes in Kazakhstan
- Crisis-hit Valencia hire West Brom's Corberan as new boss
- Suriname ex-dictator and fugitive Desi Bouterse dead at 79
- 35 feared dead as Azerbaijani jet crashes in Kazakhstan
- Pope calls for 'arms to be silenced' in Christmas appeal
- Syria authorities say torched 1 million captagon pills
- Pope calls for 'arms to be silenced' across world
- 32 survivors as Azerbaijani jet crashes in Kazakhstan
- Pakistan air strikes kill 46 in Afghanistan, Kabul says
- Liverpool host Foxes, Arsenal prepare for life without Saka
- Japan FM raises 'serious concerns' over China military buildup
- Pope's sombre message in Christmas under shadow of war
- Zelensky condemns Russian 'inhumane' Christmas attack on energy grid
- Sweeping Vietnam internet law comes into force
- Pope kicks off Christmas under shadow of war
- Catholics hold muted Christmas mass in Indonesia's Sharia stronghold
- Japan's top diplomat in China to address 'challenges'
- Thousands attend Christmas charity dinner in Buenos Aires
- Demand for Japanese content booms post 'Shogun'
- As India's Bollywood shifts, stars and snappers click
- Mystery drones won't interfere with Santa's work: US tracker
- Djokovic eyes more Slam glory as Swiatek returns under doping cloud
- Australia's in-form Head confirmed fit for Boxing Day Test
- Brazilian midfielder Oscar returns to Sao Paulo
- 'Wemby' and 'Ant-Man' to make NBA Christmas debuts
- US agency focused on foreign disinformation shuts down
- On Christmas Eve, Pope Francis launches holy Jubilee year
- 'Like a dream': AFP photographer's return to Syria
- Chiefs seek top seed in holiday test for playoff-bound NFL teams
- Panamanians protest 'public enemy' Trump's canal threat
- Cyclone death toll in Mayotte rises to 39
- Ecuador vice president says Noboa seeking her 'banishment'
- Leicester boss Van Nistelrooy aware of 'bigger picture' as Liverpool await
- Syria authorities say armed groups have agreed to disband
- Maresca expects Man City to be in title hunt as he downplays Chelsea's chancs
- Man Utd boss Amorim vows to stay on course despite Rashford row
- South Africa opt for all-pace attack against Pakistan
- Guardiola adamant Man City slump not all about Haaland
- Global stocks mostly higher in thin pre-Christmas trade
- Bethlehem marks sombre Christmas under shadow of war
- NASA probe makes closest ever pass by the Sun
Featured
Last news
Thai dissident jailed for two more years over royal defamation
One of Thailand's most prominent human rights activists was sentenced to two years in prison Tuesday under the kingdom's royal defamation law, his fifth conviction on the controversial charges, a legal rights group said.
Chinese plus-size influencer spreads body positivity through fashion
Surrounded by racks of colourful dresses and blazers in China's manufacturing hub of Guangzhou, plus-size clothing brand owner and influencer Amanda Yao is on a mission to promote body positivity.
Deepfakes weaponised to target Pakistan's women leaders
Pakistani politician Azma Bukhari is haunted by a counterfeit image of herself -- a sexualised deepfake video published to discredit her role as one of the nation's few female leaders.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 03
The Company announces that on 02 December 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1
Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root, achieving reversal to near pre-diabetic levels
NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders
NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (NLS), a biopharmaceutical company, is pleased to share preclinical data demonstrating the potential of its dual orexin receptor agonist (DOXA) platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed to target both orexin-1 (OX1R) and orexin-2 (OX2R) receptors while concurrently inhibiting cathepsins. Cathepsins play significant roles in a variety of physiological processes and may offer a novel therapeutic approach for narcolepsy and other neurological disorders.
CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s
Targeting a booming $6 billion U.S. edibles market with a projected $3 million in first-year revenue, CBDL delivers an innovative solution for Alzheimer's care.
Modular Medical Announces Conference Call to Provide Business Update
Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.
Rich Products to Celebrate #GivingTuesday with $80,000 in Grants to Food-Related Nonprofits
The initiative pays homage to Rich's impending 80th anniversary
M2i Global, Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
, a company specializing in the development and execution of a complete global value supply chain for critical minerals, today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.
LQR House Inc. Secures Liquor Control Board of Ontario (LCBO) Approval for SWOL Tequila in Ontario
First 1,000 Bottles Ordered by Of The Earth Distribution Corp., Marking Key Milestone in Canadian Market Expansion
BloomZ Partners with Badge Inc. to Revolutionize Fan Club Management
BloomZ Inc. (NASDAQ:BLMZ) ("BloomZ" or the "Company"), a leading Japanese anime production, audio production, and voice actor management company, announced a strategic business partnership with Badge Inc. ("Badge"), a Tokyo-based company specializing in online salon and fan club platforms.
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
- STAR-1 topline results expected in March 2025 -- Over 30 million acne patients seek treatment in the U.S. each year -- Phase 2b for DMT310 achieved statistically significant results for all primary endpoints -
Firstleaf Introduces New Holiday Wine Offerings Featuring Curated Bundles for Every Celebration
Firstleaf, the most personalized wine company in America, is ringing in the holiday season with a new selection of exclusive wine bundles designed to elevate festive gatherings and gift giving. Expertly curated by Firstleaf's wine team, these bundles feature wines from around the world and offer something special for every celebration.
Enable Me Finds Improved Clinic Workflow, Patient Safety and Help with Staff Shortages are Among the Benefits of the Clinically Designed VELA Mammography Chair, Per an Informal Survey of Clinicians
The cost/benefit implications of applying the VELA Chair as an extension of the clinical team and a time saver point to a clear return on investment in the short term."For the patients who need it, it has absolutely streamlined and improved the workflow. I no longer need to have a second tech in the room to assist patients who are unstable on their feet or unable to stand."
Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.
The International Surface Event Highlights New Offerings and Product Discovery Ahead of January Event
The International Surface Event (tise), the largest flooring, stone and tile show in North America, returns to the Mandalay Bay Convention Center, January 28-30 (Education January 27-30), 2025, for three full days of exhibits and education from the industry's most innovative sources. With thousands of products on display and dynamic show-floor demonstrations of best practice, tise is an indispensable event for the surface, stone and tile industries where the widest range of products on the market are available under one roof, with more than 700 global brands showcasing materials, surfaces and flooring solutions. Bringing together over 21,000 industry professionals annually, attendees can discover the latest products, explore new trends and advance careers through education, certifications and networking opportunities.
CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy
CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cannabis cultivation, is steadily advancing its position in high-efficiency cannabis production. The Company is excited to share its latest updates with shareholders and prospective investors, highlighting its substantial progress, current operations, and future growth plans.
Lakeland Industries to Attend Upcoming Investor Conferences in December
Lakeland Industries, Inc. (NASDAQ:LAKE) (the "Company" or "Lakeland"), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders on the federal, state and local levels, today announced that management will attend the Benchmark 13thAnnual Discovery One-on-One Conference and the 13th Annual ROTH Deer Valley Event in December 2024.
Ensysce Biosciences Announces 1-for-15 Reverse Stock Split
Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on Friday, December 6, 2024, effective at 12:01 a.m. Eastern Time, it will implement a 1-for-15 reverse split of its common stock. The Company's common stock will begin trading on a split-adjusted basis when the market opens on December 6, 2024, under its current trading symbol "ENSC". The new CUSIP number of the Company's common stock following the reverse stock split will be 293602 504.
Aytu BioPharma Disclosure Notification
DENVER, CO / ACCESSWIRE / December 3, 2024 / SUMMARY NOTICE OF PENDENCY OF DERIVATIVE ACTION, AGREEMENT OF SETTLEMENT AND RELEASE WITH RESPECT TO CERTAIN PARTIES, AND SETTLEMENT HEARING IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE LITIGATION STYLED WITMER V. ARMISTICE CAPITAL LLC, ET AL., NO. 2022-0807-MTZ (THE "ACTION").
Musk $55.8 bn Tesla pay deal again rejected by US judge
A US judge on Monday upheld her decision to reject Elon Musk's massive $55.8 billion compensation package at Tesla, denying an attempt to restore the pay deal through a shareholder vote.
Vietnam property tycoon on death row faces appeal verdict
A Vietnamese property tycoon sentenced to death for a multi-billion-dollar fraud will learn Tuesday whether her life will be spared, as an appeal court reaches its verdict on one of the biggest corruption cases in history.
18 convicted in biggest UK drugs trial
A court has sentenced 18 members of an international crime group behind Britain's "biggest ever detected drugs conspiracy" to up to 32 years in jail after the country's longest-running criminal trial, police said Monday.
Suspect freed from custody over suicide capsule death in Switzerland
A man held since September over the death of a US woman inside a controversial suicide capsule in Switzerland was released from custody Monday, though he remains under suspicion.
Najib says bribery, power abuse charges 'politically motivated'
Malaysia's jailed ex-leader Najib Razak began his defence Monday against graft charges tied to more than $500 million in alleged bribes and several counts of money laundering, saying they were "politically motivated".
'Future of planet' at stake at ICJ hearings: Vanuatu
The future of the planet is at stake during hearings at the top United Nations court, a representative for Vanuatu said Monday, opening a historic case that aims to set a legal framework on how countries should tackle climate change.
30-strong Japan A-bomb delegation to collect Nobel prize
Japanese atomic bomb survivors' group Nihon Hidankyo said Monday a 30-strong delegation will collect its Nobel Peace Prize in Oslo after a crowd-funding campaign to pay their travel costs.
Four decades of horror after India's Bhopal gas disaster
Just after midnight as poisonous plumes of smoke wafted through the Indian city of Bhopal four decades ago, Gas Devi was born, gasping for every breath.
Biden pardons son Hunter in final weeks of presidency
US President Joe Biden on Sunday issued an official pardon for his son Hunter, who is facing sentencing for two criminal cases, despite assurances that he would not intervene in his legal troubles.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 02
Purchase of own shares
BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide
BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally identified as BNT24005. This innovative product is intended to address limitations of existing administration methods for a therapeutic developed by Novo Nordisk, with the aim of improving patient accessibility and convenience. This product is currently under development and remains subject to regulatory review and approval.